World-Renowned Prostate Cancer Surgeon, Dr. David Samadi, Uses a “Treat and Teach” Approach to the International Fight Against Prostate Cancer.
As creator of the Samadi Modified Advanced Robotic Technique (SMART), a prostate removal surgery, Dr. David Samadi has helped over 4,000 men around the world overcome prostate cancer. His innovative approach to robotic prostate surgery leverages the advanced technology of the da Vinci Surgical System robot for enhanced dexterity and visibility during surgery.
Blending his years of expertise in open prostate surgery, laparoscopic surgery, and robotic surgery, Dr. Samadi yields superior results with regard to prostate cancer cure rate and quality of life after prostate removal surgery. Through his regular “treat and teach” overseas trips, Dr. Samadi performs his SMART surgery for the benefit of both patients and prostate cancer specialist throughout the world.
“Men, regardless of nationality, have the same priorities when it comes to fighting prostate cancer. They want to the opportunity to enjoy a long life with family and friends. This means providing patients with the best possible care.”
In the U.S., Dr. Samadi’s practice has a dedicated international department welcoming men from countries throughout Europe, many from France, Spain, Germany, the Netherlands, Russia, Greece, and Italy. “My staff is multilingual and willingly handles all aspects of travel and accommodations for patients and their families. We receive many compliments for the warmth and discretion shown to our patients,” said Dr. Samadi. Many men travel to Dr. Samadi’s office each week for SMART prostate removal surgery, which requires only a one-night hospital stay.
Travel to the United States is considered a small step for men in the fight of their lives. Dr. Samadi’s SMART surgery makes the trip worthwhile in many ways.
• 97% of Dr. Samadi’s patients are cancer-free with a zero PSA after surgery
• 96% of Dr. Samadi’s patients regain urinary control within 12 months of surgery
• 85% of Dr. Samadi’s patients regain sexual potency within 12-24 months of surgery
• He is the first surgeon in the United States to successfully perform a robotic surgery redo, demonstrating mastery of the da Vinci robotic system and proven ability to medically help patients with low and high risks of prostate cancer.
“Global medicine is extremely important to me,” said Dr. Samadi, “My medical training in the U.S. affords me the opportunity to successfully diagnose and treat all aspects of prostate cancer. The hands-on care and prostate surgery success I am able to achieve is available to all men, regardless of location.”
To learn more about Dr. Samadi’s SMART surgery or for an introduction to other French patients of Dr. Samadi’s, contact Ann Angcaya at 212 241-4931 or visit www.roboticoncology.com. Both options will provide a detailed explanation of the procedure, results, and travel information in French.
Dr. Samadi serves as Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at Mount Sinai Medical Center.